The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 24,165 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 14,018 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 8,401 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 2,583 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 45,315 | 385,000 | SH | SOLE | 385,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 21,775 | 185,000 | SH | Put | SOLE | 185,000 | 0 | 0 | |
AXSOME THERAPEUTICS INC | COM | 05464T104 | 4,411 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 4,070 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 9,007 | 175,000 | SH | Call | SOLE | 175,000 | 0 | 0 | |
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 6,829 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 19,212 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 9,960 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 811 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CHIASMA INC | COM | 16706W102 | 3,640 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 6,138 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 6,554 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 6,195 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 625 | 11,500 | SH | SOLE | 11,500 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 17,680 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
INVESCO CURNCYSHS SWISS FRAN | SWISS FRANC | 46138R108 | 8,574 | 91,800 | SH | SOLE | 91,800 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 15,879 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
GENOCEA BIOSCIENCES INC | COM | 372427104 | 1,180 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 15,368 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 10,937 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 11,448 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 5,544 | 2,100,000 | SH | SOLE | 2,100,000 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 7,265 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 10,995 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
OBSEVA SA | COM | H5861P103 | 2,558 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 5,364 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 8,799 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 6,720 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 10,524 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
RETROPHIN INC | COM | 761299106 | 11,315 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 11,929 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 920 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 5,793 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 5,543 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 14,716 | 80,000 | SH | SOLE | 80,000 | 0 | 0 |